SWOG 0514: A phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

Por El-Khoueiry, Anthony B., Rankin, Cathryn J., Ben-Josef, Edgar, Lenz, Heinz-Josef, Gold, Philip J., Hamilton, R. Darryl, Govindarajan, Rangaswamy, Eng, Cathy, Blanke, Charles D.
Publicado em 2011

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Por Rutkowski, Piotr, Van Glabbeke, Martine, Rankin, Cathryn J., Ruka, Wlodzimierz, Rubin, Brian P., Debiec-Rychter, Maria, Lazar, Alexander, Gelderblom, Hans, Sciot, Raf, Lopez-Terrada, Dolores, Hohenberger, Peter, van Oosterom, Allan T., Schuetze, Scott M.
Publicado em 2010

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

Por Bohanes, Pierre, Rankin, Cathryn J., Blanke, Charles D., Winder, Thomas, Ulrich, Cornelia M., Smalley, Stephen R., Rich, Tyvin A., Martensen, James A., Benson, Al B., Mayer, Robert J., Cripps, Christine M., Danenberg, Kathleen, Makar, Karen W., Zhang, Wu, Benedetti, Jacqueline K., Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2015)